Multimorbidity Linked to Alzheimer's Biomarkers in Dementia-Free Adults

As the global population ages, the clinical reality of multimorbidity, defined as the coexistence of two or more chronic conditions, has become the rule rather than the exception in primary and specialty care [1, 2]. While clinicians have long observed that patients with complex medical histories face a higher risk of functional decline, the specific pathways linking systemic health to neurodegenerative processes remain poorly defined [3, 4]. Current evidence suggests that physical and psychological comorbidities can more than double the risk of developing clinical dementia, yet most disease-modifying trials for Alzheimer's disease continue to exclude these complex patients [5, 6]. This gap in external validity leaves practitioners with limited data on how common ailments like hypertension or diabetes interact with the underlying proteopathy of cognitive decline [7]. A recent large-scale analysis now examines these mechanistic links by evaluating how total chronic disease burden correlates with specific biomarkers of neurodegeneration and vascular injury.